FindTrial
Sign In

To study the intervention effect of smile therapy based on continuous nursing on dry eye syndrome in patients undergoing cataract surgery

To study the intervention effect of smile therapy based on continuous nursing on dry eye syndrome in patients undergoing cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102758
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye syndrome

Interventions

Laughter therapy intervention (experimental group only):1. Laughter Therapy Schedule Starting from the first week post-surgery, repeat the cue 30 times in each session, four times a day. Patients ar
Routine care (implemented in both the experimental and control groups):1. Anti-inflammatory Treatment Use anti-inflammatory eye drops as prescribed, typically four times a day for four weeks.

Sponsors

Shanghai Eye Disease Prevention and Treatment Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Undergoing cataract surgery in one eye, with no recent plans for surgery in the other eye. 2. Able to cooperate with and complete various eye examinations before and after surgery. 3. Patients who voluntarily agree to participate in the study and sign the informed consent form. 4. Meet the diagnostic criteria for dry eye. 5. Basic health status: no severe eye diseases, no severe systemic diseases, and no conditions affecting the treatment of dry eye or the intervention of laughter therapy.

Exclusion criteria

Exclusion criteria: 1. Suffering from other ocular surface diseases affecting efficacy evaluation, such as ocular trauma, keratoconjunctivitis, uveitis, glaucoma, etc. 2. Combined with meibomian gland dysfunction, abnormal lid margin and meibomian gland openings, abnormal meibum secretion, etc. 3. Use of medications affecting tear secretion function within the past 6 months, such as antihistamines, antidepressants, or various artificial tears. 4. History of ocular surgeries within theygium removal. 5. Exclude participants who cannot use smartphones, tablets, or other digital devices, ensuring smooth intervention implementation. 6. Mental or cognitive disorders: patients with significant mental disorders (such as depression, anxiety) or cognitive impairment who cannot complete the intervention as required by the study.

Design outcomes

Primary

MeasureTime frame
Dry Eye Symptom Scoring;Ocular Surface Examination Indicators ;Health Status Measurement (SF-36) ;Participation and Satisfaction in Laughter Therapy ;—

Countries

China

Contacts

Public ContactTan Yuehong

Shanghai Eye Disease Prevention and Treatment Center

363510021@qq.com+86 150 0015 5579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026